The (Un)usual Suspects
Don’t be afraid to tackle unusual cases. Given the right precautions, they can be just as successful as routine procedures
Audrey R. Talley Rostov | | Longer Read
In the past seven or eight years, I have treated more than 1,000 eyes with corneal collagen cross-linking (CXL), first as part of the CXL-USA study and later with the Avedro KXL system. The majority of these cases have been typical patients with progressive keratoconus – older teens and adults in their 20s and 30s — but it is worth discussing how to address less common CXL cases that surgeons may encounter.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine